Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Aug 1;12(4):856-63.
doi: 10.5114/aoms.2015.51188. Epub 2016 Mar 4.

Selected tumor markers in the routine diagnosis of chromophobe renal cell carcinoma

Anna M Badowska-Kozakiewicz  1 , Michał P Budzik  2 , Paweł Koczkodaj  1 , Jacek Przybylski  1
Affiliations

Selected tumor markers in the routine diagnosis of chromophobe renal cell carcinoma

Anna M Badowska-Kozakiewicz et al. Arch Med Sci. .

Abstract

Renal cell carcinoma is one of the most malignant tumors, affecting men more frequently than women and constituting nearly 90% of all kidney tumors. Chromophobe renal cell carcinoma has been described as a new histological type of renal cell carcinoma. Chromophobe renal cell carcinoma constitutes up to 5% of all cases of kidney cancer. It is characterized by a significant number of deletions in many chromosomes, as well as the loss of entire chromosomes. Chromophobe renal cell carcinoma arises from tubular cells or cells of the macula densa. In contrast to other types of kidney cancer, it occurs with equal frequency in men and women, mostly in the sixth decade of life. It is characterized by a relatively good prognosis and exhibits a low degree of malignancy. Histopathologic diagnosis of ChRCC can be a diagnostic challenge because these tumors may resemble oncocytoma or conventional cancer. Research by Mathers et al. proposed the use of cytokeratin 7 as a marker useful in the differentiation of these changes.

Keywords: CD117; KAI1 protein; chromophobe renal cell carcinoma; tumor markers.

PubMed Disclaimer

References

    1. Clague J, Lin J, Cassidy A, et al. Family history and risk of renal cell carcinoma: results from a case-control study and systematic meta-analysis. Cancer Epidemiol Biomarkers Prev. 2009;18:801–7. - PMC - PubMed
    1. Chow WH, Dong LM, Davesa SS. Epidemiology and risk factors for kidney cancer. Nat Rev Urol. 2010;7:245–57. - PMC - PubMed
    1. Fengqiang Y, Yang S, Fengping Y, et al. Valproic acid upregulates NKG2D ligand expression and enhances susceptibility of human renal carcinoma cells to NK cell-mediated cytotoxicity. Arch Med Sci. 2013;9:323–31. - PMC - PubMed
    1. Kruś S, Skrzypek-Fakhoury E. The surface morphology of kidney diseases. In: Kruś S, Skrzypek-Fakhoury E, editors. Clinical pathology. 3rd ed. Warsaw: Publisher Medical PZWL; 2011. pp. 545–606.
    1. Cotran RS, Rennke H, Kumar V. Kidney and roads discharging urine. Tumors. In: Kumar V, Cotran RS, Robbins SL, editors. Robbins pathology. Wroclaw: Elsever Urban & Partner; 2009. pp. 615–9.